Company intelligence / Profile preview

Guilin Huns

Guilin, Guangxi, China

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Guilin Hunsun Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of chemical drugs and traditional Chinese medicines. The company is particularly known for its focus on digestive system treatments, including proton pump inhibitors and gastroprotective agents. Beyond gastroenterology, Hunsun produces a range of products for cardiovascular health and anti-infective applications. Operating out of Guilin, the company maintains GMP-certified manufacturing facilities and serves both domestic and international markets.

Therapeutic areas: CardiovascularInfectious DiseasesGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Guilin Huns.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guilin Huns.

Explore the full profile